Table 5.
Clinical features of six patients with HBV reactivation secondary to rituximab therapy
*Baseline test.
Pt., patient; M, male; F, female; ALT, alanine aminotransferase; TB, total bilirubin; NA, not available; LMV, lamivudine; ETV, entacavir; ADV, adefovir; LT, liver transplantation.